Cargando…
In vitro antagonism between cisplatin and vinca alkaloids.
The effects of the combination of cisplatin and other cytotoxic agents were studied in vitro. When A549 lung cancer cells were treated simultaneously with cisplatin and other cytotoxic agents, cisplatin additively increased the cytotoxic effects of etoposide, mitomycin C, adriamycin, 5-fluorouracil...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1989
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246974/ https://www.ncbi.nlm.nih.gov/pubmed/2757923 |
_version_ | 1782150882384674816 |
---|---|
author | Lee, K. Tanaka, M. Kanamaru, H. Hashimura, T. Yamamoto, I. Konishi, J. Kuze, F. |
author_facet | Lee, K. Tanaka, M. Kanamaru, H. Hashimura, T. Yamamoto, I. Konishi, J. Kuze, F. |
author_sort | Lee, K. |
collection | PubMed |
description | The effects of the combination of cisplatin and other cytotoxic agents were studied in vitro. When A549 lung cancer cells were treated simultaneously with cisplatin and other cytotoxic agents, cisplatin additively increased the cytotoxic effects of etoposide, mitomycin C, adriamycin, 5-fluorouracil and 1-beta-D-arabinofuranosylcytosine, but antagonised those of vincristine, vindesine, vinblastine and podophyllotoxin. The antagonism between cisplatin and vincristine was also observed with HT29 colon cancer cells. NC65 renal carcinoma cells and A431 epidermoid carcinoma cells when these cells were simultaneously exposed to both agents. When A549 cells were exposed to cisplatin and vincristine sequentially, the antagonism between them was evident when cells were pretreated with cisplatin but not when treated in the opposite sequence. Therefore, when combination chemotherapy including cisplatin and vinca alkaloids is given, possible antagonism between them should be considered, especially in determining the schedule of drug administration. IMAGES: |
format | Text |
id | pubmed-2246974 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1989 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-22469742009-09-10 In vitro antagonism between cisplatin and vinca alkaloids. Lee, K. Tanaka, M. Kanamaru, H. Hashimura, T. Yamamoto, I. Konishi, J. Kuze, F. Br J Cancer Research Article The effects of the combination of cisplatin and other cytotoxic agents were studied in vitro. When A549 lung cancer cells were treated simultaneously with cisplatin and other cytotoxic agents, cisplatin additively increased the cytotoxic effects of etoposide, mitomycin C, adriamycin, 5-fluorouracil and 1-beta-D-arabinofuranosylcytosine, but antagonised those of vincristine, vindesine, vinblastine and podophyllotoxin. The antagonism between cisplatin and vincristine was also observed with HT29 colon cancer cells. NC65 renal carcinoma cells and A431 epidermoid carcinoma cells when these cells were simultaneously exposed to both agents. When A549 cells were exposed to cisplatin and vincristine sequentially, the antagonism between them was evident when cells were pretreated with cisplatin but not when treated in the opposite sequence. Therefore, when combination chemotherapy including cisplatin and vinca alkaloids is given, possible antagonism between them should be considered, especially in determining the schedule of drug administration. IMAGES: Nature Publishing Group 1989-01 /pmc/articles/PMC2246974/ /pubmed/2757923 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Article Lee, K. Tanaka, M. Kanamaru, H. Hashimura, T. Yamamoto, I. Konishi, J. Kuze, F. In vitro antagonism between cisplatin and vinca alkaloids. |
title | In vitro antagonism between cisplatin and vinca alkaloids. |
title_full | In vitro antagonism between cisplatin and vinca alkaloids. |
title_fullStr | In vitro antagonism between cisplatin and vinca alkaloids. |
title_full_unstemmed | In vitro antagonism between cisplatin and vinca alkaloids. |
title_short | In vitro antagonism between cisplatin and vinca alkaloids. |
title_sort | in vitro antagonism between cisplatin and vinca alkaloids. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2246974/ https://www.ncbi.nlm.nih.gov/pubmed/2757923 |
work_keys_str_mv | AT leek invitroantagonismbetweencisplatinandvincaalkaloids AT tanakam invitroantagonismbetweencisplatinandvincaalkaloids AT kanamaruh invitroantagonismbetweencisplatinandvincaalkaloids AT hashimurat invitroantagonismbetweencisplatinandvincaalkaloids AT yamamotoi invitroantagonismbetweencisplatinandvincaalkaloids AT konishij invitroantagonismbetweencisplatinandvincaalkaloids AT kuzef invitroantagonismbetweencisplatinandvincaalkaloids |